The Journal of Allergy and Clinical Immunology: In Practice
Volume 9, Issue 12, December 2021, Pages 4470-4472.e1
Clinical CommunicationsTolerability of polysorbate 80–containing COVID-19 vaccines in confirmed polyethylene glycol–allergic patients
Cited by (0)
C. Breynaert is supported by a KOOR fellowship (UZ Leuven). R. Schrijvers is a senior clinical investigator fellow of the Fonds Wetenschappelijk Onderzoek—Vlaanderen, National Fund for Scientific research (FWO, 1805518N).
Conflicts of interest: The authors declare that they have no relevant conflicts of interest.
- ∗
These authors contributed equally to this work.
© 2021 American Academy of Allergy, Asthma & Immunology